Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
Thermo Fisher typically reports earnings before the market opens, meaning Day 0 represents the first full trading session where investors react to results, while Day +1 captures follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-04-23 | -$47.28 (-9.20%) | $20.78 (4.04%) | +$3.01 (+0.64%) | $10.34 (2.22%) |
| 2026-01-29 | -$15.86 (-2.61%) | $24.14 (3.97%) | -$13.55 (-2.29%) | $11.72 (1.98%) |
| 2025-10-22 | +$9.21 (+1.65%) | $20.41 (3.66%) | +$4.71 (+0.83%) | $15.86 (2.80%) |
| 2025-07-23 | +$39.09 (+9.14%) | $22.38 (5.23%) | +$8.32 (+1.78%) | $19.56 (4.19%) |
| 2025-04-23 | -$3.09 (-0.71%) | $32.19 (7.40%) | -$4.98 (-1.15%) | $14.67 (3.40%) |
| 2025-01-30 | +$38.51 (+6.78%) | $20.97 (3.69%) | -$8.99 (-1.48%) | $8.05 (1.33%) |
| 2024-10-23 | -$9.89 (-1.69%) | $12.61 (2.15%) | -$19.11 (-3.31%) | $17.57 (3.05%) |
| 2024-07-24 | +$22.49 (+4.07%) | $22.60 (4.09%) | +$19.77 (+3.44%) | $31.69 (5.51%) |
| Avg Abs Move | 4.48% | 4.28% | 1.87% | 3.06% |
The historical price behavior around Thermo Fisher earnings reveals significant volatility, with an average absolute Day 0 move of 4.48% and a Day 0 range of 4.28%. The most recent April 2026 report triggered the largest reaction in the dataset, with the stock plunging -9.20% despite beating estimates, suggesting investors were disappointed by guidance or forward commentary. This contrasts sharply with the July 2025 report, which saw a +9.14% surge on the day of release.
The directional pattern is mixed, with four of the past eight reports producing positive Day 0 moves and four negative, indicating no clear bias in how the market responds. However, the magnitude of moves has been substantial — six of the eight reports saw Day 0 moves exceeding 4%, and three exceeded 6%. The Day +1 follow-through has been more muted, averaging 1.87%, though the April 2026 report showed a modest +0.64% recovery after the initial selloff.
The Day 0 range of 4.28% suggests intraday volatility is nearly as large as the directional move itself, meaning investors should expect wide swings between the opening print and closing price. The current options-implied move of 4.81% is slightly above the historical Day 0 average, indicating the market is pricing in elevated uncertainty for this release — likely reflecting the mixed technical setup and deteriorating analyst sentiment heading into the print.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 07/24/26 (DTE 2) |
| Expected Move | $25.31 (4.81%) |
| Expected Range | $501.15 to $551.77 |
| Implied Volatility | 101.31% |
The options market is pricing a 4.81% expected move for this earnings release, which sits slightly above the 4.48% average historical Day 0 move but well within the range of recent volatility. This suggests options traders are anticipating a typical Thermo Fisher earnings reaction, with no outsized surprise priced in relative to the stock's established pattern of 4–9% post-earnings swings.
Part 3: What Analysts Are Saying
Analysts maintain a bullish stance on Thermo Fisher, with the current average recommendation of 4.58 reflecting strong buy sentiment. The breakdown shows 20 Strong Buys, 1 Moderate Buy, and 5 Holds, with no sell ratings among the 26 analysts covering the stock. This concentration of positive ratings underscores Wall Street's confidence in the company's long-term fundamentals and market position.
However, sentiment has deteriorated over the past month, with the average recommendation slipping from 4.64 to 4.58 as one analyst shifted from a buy to a hold. This modest downgrade suggests some caution is creeping into the narrative, likely tied to concerns about near-term growth visibility or valuation after the stock's recent run above its 50-day and 100-day moving averages.
The consensus price target of $596.88 implies +13.4% upside from the current price of $526.46, offering a meaningful reward for investors willing to look past near-term volatility. The range of targets is wide, spanning from a low of $490 (implying -6.9% downside) to a high of $750 (implying +42.5% upside), reflecting divergent views on the company's ability to sustain its growth algorithm and margin expansion into 2027. The mean target suggests analysts see the stock as modestly undervalued at current levels, though the recent sentiment deterioration and wide target dispersion indicate the path to that upside is far from certain.
Part 4: Technical Picture
The Barchart Technical Opinion has shifted dramatically in recent weeks, moving from an 88% Sell signal one month ago to a 24% Buy signal last week and now registering just an 8% Buy as of the latest reading. This rapid deterioration in the technical signal suggests momentum has stalled after a brief recovery attempt, leaving the stock in a precarious position heading into earnings.
Timeframe Analysis:
- Short-term (50% Buy): Moderate buy signal indicates near-term momentum is neutral to slightly positive, reflecting recent consolidation after the stock's move above key moving averages
- Medium-term (50% Sell): Moderate sell signal suggests the intermediate-term trend remains under pressure, with resistance likely capping upside attempts
- Long-term (Hold): Neutral reading reflects a lack of conviction in the longer-term trend, as the stock trades near its 200-day moving average
Trend Characteristics: The signal strength is rated as Minimum with a Weakening direction, indicating the technical environment is fragile and lacks the conviction needed to support a sustained breakout — a cautionary setup for a high-volatility earnings event.
The stock is currently trading at $526.46, positioned below its 5-day ($530.36), 10-day ($530.15), and 200-day ($529.43) moving averages, but above its 20-day ($520.07), 50-day ($487.42), and 100-day ($489.08) moving averages. This mixed picture suggests the stock is caught in a tug-of-war between short-term resistance and intermediate-term support. The fact that TMO is trading just below its 200-day moving average — a key long-term trend indicator — adds significance to this earnings release, as a strong beat could propel the stock through overhead resistance, while a miss or weak guidance could trigger a retest of the 50-day and 100-day support levels.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $530.36 | 50-Day MA | $487.42 |
| 10-Day MA | $530.15 | 100-Day MA | $489.08 |
| 20-Day MA | $520.07 | 200-Day MA | $529.43 |
Key technical levels to watch include the $530 area (5-day and 10-day moving averages), which has acted as near-term resistance, and the $520 level (20-day moving average), which represents initial support. A break above $530 on strong earnings could open the door to a test of the $550–$552 range implied by the options expected move, while a disappointment could send the stock back toward the $500–$501 lower bound of the expected range or even the rising 50-day moving average near $487. The overall technical setup is cautionary heading into earnings — the weakening momentum, minimum signal strength, and position just below the 200-day moving average suggest the stock lacks the technical cushion to absorb a negative surprise, making execution and guidance commentary critical to determining whether TMO can reclaim its uptrend or faces further consolidation.